212
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Inhaled iloprost for therapy in pulmonary arterial hypertension

, , &
Pages 145-152 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lewis J Rubin & Nicholas W Morrell. (2011) New frontiers in pulmonary hypertension. Expert Review of Respiratory Medicine 5:2, pages 139-140.
Read now

Articles from other publishers (8)

Fekadu Kassie, Alireza Jian Bagherpoor, Katalin Kovacs & Davis Seelig. (2022) Combinatory lung tumor inhibition by myo-inositol and iloprost/rapamycin: association with immunomodulation. Carcinogenesis 43:6, pages 547-556.
Crossref
Vinit Agnihotri, Yogeeta Agrawal, Sameer Goyal, Charu Sharma & Shreesh Ojha. (2022) An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension. Molecules 27:11, pages 3490.
Crossref
Richard Truse, Jonas Hinterberg, Jan Schulz, Anna Herminghaus, Andreas Weber, Tabea Mettler-Altmann, Inge Bauer, Olaf Picker & Christian Vollmer. (2017) Effect of Topical Iloprost and Nitroglycerin on Gastric Microcirculation and Barrier Function during Hemorrhagic Shock in Dogs. Journal of Vascular Research 54:2, pages 109-121.
Crossref
Shuyan Gu, Huimei Hu & Hengjin Dong. (2016) Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension. PharmacoEconomics 34:8, pages 751-770.
Crossref
Luis Efren Santos-Martínez, Francisco Martín Baranda-Tovar, Eslí Telona-Fermán, Rodolfo Barragán-García & Moisés Cutiel Calderón-Abbo. (2015) Iloprost inhalado, un vasodilatador pulmonar selectivo. Evidencia clínica de su uso en la hipertensión pulmonar del perioperatorio de cirugía cardiovascular. Archivos de Cardiología de México 85:2, pages 136-144.
Crossref
Luis Efren Santos-Martínez, Luis Antonio Moreno-Ruiz, Moisés Jiménez-Santos, Sergio Gabriel Olmos-Temois, Luis Armando Bojorquez-Guerrero & Francisco Martín Baranda-Tovar. (2014) Utilidad clínica del iloprost inhalado en la hipertensión arterial pulmonar. Archivos de Cardiología de México 84:3, pages 202-210.
Crossref
Jonathan Rhodes, Ana Ubeda-Tikkanen, Mathieu Clair, Susan M. Fernandes, Dionne A. Graham, Carly E. Milliren, Kevin P. Daly, Mary P. Mullen & Michael J. Landzberg. (2013) Effect of inhaled iloprost on the exercise function of Fontan patients: A demonstration of concept. International Journal of Cardiology 168:3, pages 2435-2440.
Crossref
W. Mosgoeller, R. Prassl & A. Zimmer. 2012. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases 325 354 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.